OncoMyx Therapeutics targets hematologic and solid tumors with unique oncolytic virus called myxoma (MYXV) and a novel patented systemic delivery approach. The myxoma program is the result of two decades of oncolytic virus research in the laboratory of Professor Grant McFadden. Myxoma is a pox virus that is highly immunostimulatory, and is non-pathogenic in any organism outside of rabbits. The virus has a unique ability to be carried systemically by human leukocytes where it can then infect tumor cells. Programs are in development for both hematology (myeloma and AML) as well as solid tumors. Professor McFadden sequenced the myxoma virus genome in 1999, and since then has produced dozens of genetically engineered constructs, demonstrating its ability as an oncolytic agent across many tumors in preclinical cell and animal models.
Company Details
- Employees
- 3
- Founded
- -
- Address
- 24654 N Lake Pleasant Parkway,
- Phone
- (602) 567-8064
- Industry
- Pharmaceutical Manufacturing
- NAICS
-
Pharmaceutical and Medicine ManufacturingMedicinal and Botanical ManufacturingPharmaceutical Preparation ManufacturingIn-Vitro Diagnostic Substance ManufacturingBiological Product (except Diagnostic) Manufacturing
- Website
- oncomyx.com
- Keywords
- oncolytic virus, Oncology, lung cancer, multiple myeloma, acute myeloid leukemia, bladder cancer, ovarian cancer, drug development, immunotherapy, hematology, medical oncology, virology, sarcoma, lung metastasis, w.
- HQ
- Peoria, AZ
Oncomyx Therapeutics Questions
Oncomyx Therapeutics's helpline number is (602) 567-8064
Oncomyx Therapeutics's website is oncomyx.com
Oncomyx Therapeutics's LinkedIn profile is https://www.linkedin.com/company/oncomyx
Oncomyx Therapeutics has
3 employees.
View email and phone details for 3
employees at Oncomyx Therapeutics.
Oncomyx Therapeutics's industry is
Pharmaceutical Manufacturing
Oncomyx Therapeutics's top competitors are
Calviri,
Oligon,
Surgenex,
Td2 Oncology,
Phoenix Bioscience Core,
Caris Life Sciences,
Systems Oncology,
Slam Biotherapeutics,
Humabiologics®, Inc,
Amnio Technology.
Oncomyx Therapeutics's categories are Pharmaceutical Manufacturing
Oncomyx Therapeutics's founding year is 2018
